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Over 800,000 people die by suicide each year globally, with non-fatal self-harm 20 times 
more common. With each episode of self-harm, the risks of future self-harm and suicide 
increase, as well as personal and healthcare costs. Therefore, early delineation of those 
at high risk of future self-harm is important. Historically, research has focused on clinical 
and demographic factors, but risk assessments based on these have low sensitivity to 
predict repetition. Various neurocognitive factors have been associated with self-harming 
behavior, but it is less certain if we can use these factors clinically (i) as risk markers to 
predict future self-harm and (ii) to become therapeutic targets for interventions. Recent 
systematic reviews and meta-analyses of behavioral tasks and fMRI studies point to an 
emerging hypothesis for neurocognition in self-harm: an underactive pre-frontal cortex 
is unable to respond appropriately to non-emotional stimuli, or inhibit a hyperactive 
emotionally-/threat-driven limbic system. However, there is almost no imaging data 
examining repetition of self-harm. Extrapolating from the non-repetition data, there may 
be several potential neurocognitive targets for interventions to prevent repeat self-harm: 
cognitive training; pharmacological regimes to promote non-emotional neurocognition; 
or other techniques, such as repetitive transcranial magnetic stimulation. Hence, there is 
an urgent need for imaging studies examining repetition and to test specific hypotheses. 
Until we investigate the functional neurocognitive basis underlying repetition of self-harm 
in a systematic manner using second-generational imaging techniques, we will be unable 
to inform third-generational imaging and potential future clinical applications.
Keywords: self-harm, neurocognition, functional magnetic resonance imaging, structural magnetic resonance 
imaging, risk prediction, suicide, cognitive tasks
seLF-HArM AND risK AssessMeNt FOr PreDictiON OF its 
rePetitiON
What is self-Harm and Why is it important?
Self-harm, where an individual intentionally causes physical harm to themselves by self-injury 
or self-poisoning irrespective of motivation (1, 2), affects both those with and without previously 
diagnosed mental illness. Any episode of self-harm potentially results in (i) serious morbidity or 
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(ii) death by suicide. Studies suggest that between one in 20 and 
one in 40 self-harm episodes with reported intent to die ends in 
completed suicide (3–5). Globally, over 800,000 people die by 
suicide annually (6–8), and it is estimated that by 2020, suicide 
will contribute more than 2% to the global burden of disease (9). 
In the UK, and internationally, the total number of suicides in 
the general population has been rising since 2009 (8, 10, 11) with 
this rise most marked in men aged 45–54 years (10). However, 
self-harm and suicide remain important throughout the lifespan: 
suicide is the second most common cause of death in young peo-
ple in the UK (12) with a conservative estimate of 10% of young 
people reporting at least one episode of self-harm (13).
Historically, the over-arching term “self-harm” has been 
divided into “parasuicide” (no reported intention from the indi-
vidual concerned to die) and “attempted suicide” (where there is 
a reported intention to die). However, reported intent of previous 
episodes of self-harm does not appear to correlate with future 
self-harm or suicide (14–16). This may be because of conscious 
or subconscious underreporting by the individual, or it may be 
because the pathophysiology of self-harm and the potential future 
pathway is the same regardless of previous conscious intent. For 
this reason, both the World Health Organization (WHO) and 
the UK National Institute of Health and Care Excellence (NICE) 
include all behavior regardless of method or intent in their 
definitions of self-harm (1, 2). However, intent remains used as a 
delineating factor particularly in the US to separate non-suicidal 
self-injury (NSSI) from suicidal attempts, which are then treated 
separately for clinical and research purposes. However, recent 
research shows that self-harm method switching occurs routinely 
in individuals (17). If, in fact, this dichotomy is false, by separat-
ing out self-harm on presumed or purported intent or method 
used we may be reducing the number of available participants for 
studies into self-harm.
How Have Predictors of self-Harm Been 
Approached and Analyzed?
Prevention of suicide remains difficult, partly because the 
complex underlying cognitive processes remain only partially 
understood (18, 19). The few successful prevention strategies 
have appeared to focus on public health level interventions, 
such as paracetamol sale restrictions (20). Suicide prevention 
is in need of markers that predict future self-harm and serve 
as a basis for intervention (21). To date, self-harm research has 
focused on retrospective identification of high-risk individuals 
following self-harm using demographic and clinical factors, e.g., 
age, sex, diagnosis of mental illness (22–25). This is because this 
information is easily achievable from patient records rather than 
requiring direct patient contact (26, 27), which is more difficult, 
costly, and has many ethical implications. However, the increas-
ing suicide rate of late despite our improved understanding of 
demographic and clinical factors indicates that these factors are 
inadequate in terms of predicting future risk of self-harm alone. 
Standard risk assessment tools based on these factors, such as the 
SADPERSONS tool, do not appear to accurately predict individu-
als requiring psychiatric admission or community aftercare, or to 
predict those who repeat self-harm (28). Furthermore, the 2014 
UK confidential inquiry report on suicides in primary care found 
that 37% of those who died by suicide between 2002 and 2011 did 
not have a mental health diagnosis recorded on their GP records 
(11). This reinforces the fact that to prevent suicides we need to 
learn how to identify high-risk people in those not previously 
known to mental health services or with known mental illness.
What is Already Known about Predicting 
repetition of self-Harm?
There is almost ubiquitous evidence that the most important 
predictor of future self-harm is past self-harm (14, 29–31). After 
a first episode of self-harm, approximately one in six patients 
repeats self-harm over the first year, and one in four after 4 years 
(14). With repetition, there is an increasing risk of suicide (32) 
and increased costs personally and to the health service (33). 
Therefore, the study of prediction of repetition of self-harm is 
very important to try and reduce the personal, clinical, social, and 
financial burdens of self-harm and suicide.
Repetition of self-harm has been associated with various 
demographic and clinical factors, including (i) sociodemographics 
[extremes of age, and low educational level (30, 34), being unmar-
ried (35), and being unemployed (36)]; (ii) personal history [abuse 
in childhood (37)]; and (iii) specific mental disorder diagnosis 
[personality disorder (38), anxiety disorder (39), depression (27), 
and substance and alcohol misuse (40, 41)]. However, although up 
to 90% of people who die by suicide have a psychiatric disorder (42), 
making this a risk factor for self-harm, most people with a mental 
illness will not self-harm. Thus, psychiatric diagnosis is not very 
helpful in terms of predicting suicide or why an individual might do 
so (19). The most commonly used risk assessment tool in England 
based on clinical and demographic factors, the SADPERSONS tool 
(43), does not accurately predict individuals requiring psychiatric 
admission or community aftercare, or repeat self-harm (28).
Why is repetition of self-Harm Particularly 
important?
In the longer term, it appears possible that repetition of self-
harm in young people may act as a marker of an emerging wider 
psychopathological process, resulting in long-term contact with 
mental health services and need for care. The self-harm itself 
may or may not persist (44, 45), but young people who self-harm 
repeatedly appear at greater risk of serious mental illness and 
poor educational and occupational outcomes in later adulthood 
(45). Therefore, a greater understanding of repeat self-harm, 
and its neurobiological basis, is vital to be able to both predict 
and prevent suicide, but also to alleviate current and long-term 
mental distress, and to aid early detection of young people at high 
risk of future psychiatric difficulties.
NeUrOBiOLOGicAL BAsis FOr 
NeUrOcOGNitiON iN seLF-HArM
self-Harm as a complex clinical 
syndrome at Least Partly independent of, 
but influenced by, Diagnosis
Prediction of future risk of self-harm is likely to be enhanced if 
this non-individualized data (demographic and clinical factors) 
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could be combined with more personalized individual-based fac-
tors, such as personality and cognition. Self-harm is likely to be 
best understood as an interaction between underlying individual 
susceptibilities to self-harm (such as personality and cognitive 
factors) and current social and health stressors (such as employ-
ment or financial issues, mental and physical illness, and negative 
life events), known as a “stress–diathesis model” (18, 19, 46, 47). 
Various stress–diathesis models of self-harm exist, typically based 
on the concept that self-harm may represent a clinical syndrome 
in its own right (19, 47, 48). This is consistent with recent National 
Institute of Mental Health guidance in the US which has reported 
that it will only commission and fund future research if it crosses 
existing diagnostic boundaries and instead focuses on clinical 
syndromes (49). However, for example, Hawton et al. found that 
depression, in particular, was a consistent predictor of repetition 
(27), indicating the importance of appreciating stress–diathesis 
models within the context of potential particular psychiatric 
diagnoses (as potential and common stressors), both in terms of 
risk prediction and also for future management planning.
current evidence for Neurocognition in 
self-Harm
Although self-harm behavior includes much heterogeneity, the 
underlying demographic, clinical, and neurobiological factors 
are likely to be similar across individuals (47). There are putative 
genetic and molecular markers for self-harm behavior involv-
ing abnormalities at the neurochemical and cellular level (47). 
There has also been exploration into regional brain structural 
abnormalities in patients who have a history of self-harm and 
deficits of the associated brain functions (known as neurocog-
nitive correlates) (18, 21). These neurocognitive factors may 
act as objective markers of self-harming behavior, overcoming 
self-reporting biases (47, 50). Therefore, neuroimaging studies in 
self-harm have a vital role, allowing us to connect structural brain 
abnormalities with functional and cognitive changes, and thereby 
produce a connected neurobiological theory to suicidal behavior.
van Heeringen and colleagues have conducted several reviews 
of neuroimaging studies investigating self-harm behavior (21, 
47, 51). Their most recent systematic review and meta-analysis of 
structural and functional MRI studies examined general suicidal 
behavior in those with a mental illness only (21). They identified 
activation foci from 12 studies including 475 participants for 
meta-analysis (213 suicide attempters with mental illness, 262 
psychiatric controls), six of which examined structural findings 
only, and six functional findings only. A separate narrative review 
identified 21 studies of structural MRI and 9 studies of functional 
MRI performed in those with previous suicide attempts (47). 
Blumberg and colleagues also published a recent review into 
neurobiological risk factors identified for suicidal behavior using 
any form of neuroimaging (52), but again their review was limited 
to those studies involving suicidal behavior in the context of an 
underlying mental illness.
These reviews indicate that specific structural findings are 
associated with self-harm behavior, such as reduced gray matter 
in the orbitofrontal cortex (OFC), the dorsolateral pre-frontal 
cortex (DLPFC), the anterior cingulate cortex (ACC), the insula 
and superior temporal gyrus, and basal ganglia, and increased 
volume of the amygdala (21, 47, 51, 52). There is also evidence 
of white-matter hyperintensities, and increased inferior frontal 
white-matter tracks bilaterally (such as the uncinated fasciculus 
and the inferior orbital fasciculus), indicating deficits in the con-
nections between these structural areas (47, 52). Diffusion tensor 
imaging (DTI) studies also support anterior white-matter abnor-
malities and suicidal behavior (52), with identified abnormalities 
in frontal cortex and basal ganglia white-matter connections. 
These structural and connective abnormalities point to potentially 
impaired functioning of the amygdala–orbitofrontal–cingulate 
network (53), which prevents the amygdala from inhibiting the 
OFC and PFC, and the OFC from inhibiting the ACC appropri-
ately. Genetic factors may be involved in these changes in basic 
brain structure and circuitry. For example, pre-frontal and other 
brain volume abnormalities are seen in first-degree relatives of 
those with a history of suicidal behavior, as well as in the indi-
viduals themselves (54, 55).
Functional neuroimaging studies [fMRI, single photon emis-
sion computerized tomography (SPECT), positron emission 
tomography (PET)] and off-line neuropsychological studies 
detailed and referred to in these reviews and elsewhere have been 
used to investigate the neurocognitive correlates of these brain 
regions linked to self-harm.
 (i) Decision-making: activation of the ACC, a key player in 
effort-based decision-making (56), is different in young 
people with a previous self-harm and depression compared 
to those with depression but no self-harm (57). Involvement 
of the ACC in the process of self-harm may also explain 
findings of poorer Stroop performances off-line and dur-
ing imaging studies in those with previous self-harm (18, 
21). The OFC also appears to be related to self-harm and 
to decision-making. However, involvement of the OFC 
may relate to decisions determining reward expectation 
and delay (58), including “risky decision-making.” Off-line, 
risky decision-making has been found in euthymic patients 
with suicidal behavior as well as healthy biological relatives 
of suicide completers, suggesting that it is an endophenotype 
with trait-like characteristics (46, 59, 60).
 (ii) Emotional-processing: impaired processing of emotional 
feedback appears to be associated with self-harm behavior 
in both adults and adolescents in fMRI studies (61, 62). 
Aberrations in serotoninergic activity due to poor function-
ing of the PFC appear in patients with previous self-harm 
behavior (52), resulting in multiple deficits, including the 
ability to process emotional stimuli in a controlled man-
ner (47). Furthermore, carriers of a particular (S) allele of 
the serotonin transporter gene, 5HTTLPR, appear to have 
reduced functional connectivity between the ACC and 
amygdala (63, 64). Thereby, emotional-processing and self-
harm appear to be connected in terms of genetic, structural, 
connective, and functional studies.
 (iii) Memory: impairments in memory also seem to be present 
in patients with self-harm with and without mood disor-
der (65), although there is little in terms of neuroimaging 
evidence. Off-line, working memory and executive function 
deficits (for example, on the Iowa gambling task and verbal 
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fluency) in particular are associated with self-harm in the 
context of mood disorders (18). A recent systematic review 
of studies in psychiatric patients found that autobiographi-
cal memory was significantly less specific and more general 
in patients with a previous suicide attempt relative to those 
without, and long-term and working memory were both 
more impaired in suicide attempters than in patient and 
healthy controls (66).
In their recent synthesis and meta-analysis of the fMRI data 
relating to neurocognition and self-harm in mental illness (21), 
van Heeringen and colleagues found a cluster in the dorsal ACC 
showing increased activation in suicide attempters when compared 
to psychiatric controls during exposure to angry faces or mildly 
happy faces, while activation was reduced in suicide attempters 
versus psychiatric controls for high-risk decisions. Similarly, a 
cluster in the rostral ACC showed increased activation in suicide 
attempters compared to psychiatric controls during exposure 
to angry faces while activation was reduced in attempters com-
pared to controls during Go/No-Go tasks. Therefore, synthesis 
of evidence from off-line studies, and structural and functional 
imaging, indicates the following hypothesis of neurocognition in 
self-harm: in those with self-harm, there appears to be increased 
activation during emotional tasks (such as exposure to emotion-
ally charged faces) in the ACC, and decreased activation during 
non-emotional cognitive tasks (such as decision-making) in the 
ACC (21). In van Heeringen’s review, there were no studies found 
directly linking structural and functional changes in the brain 
in the context of self-harm (21). However, he suggests that his 
functional meta-analysis may be put in the context of the known 
structural deficits previously described above (21). In other 
words, an underactive pre-frontal cortex is unable to respond 
appropriately to non-emotional stimuli, or inhibit a hyperactive 
emotionally-/threat-driven limbic system.
current evidence for Neurocognition in 
repetition of self-Harm, and its Use in 
Prediction
Repetition of self-harm with an increasing risk of suicide can be 
understood as an “escalating disinhibition syndrome.” Therefore, 
studies examining repetition and facets of executive control 
(67) are likely to be very important, such as response inhibition, 
interference, attention, decision-making, and cognitive flexibility.
However, there is almost no imaging data examining repeti-
tion of self-harm. We recently conducted a systematic review (de 
Cates et  al., in preparation) into repetition of self-harm and 
neurocognition, which indicated that there is only one published 
conference abstract of an imaging study examining emotional-
processing (68). In terms of off-line studies, only a very few stud-
ies have examined decision-making (69–71), although each of 
these demonstrated evidence of an association between impaired 
decision-making and increased risk of repetition. There were also 
associations for repetition of self-harm with specific attentional 
biases on a modified emotional-Stroop test (72); specific results on 
the test predicted future self-harm better than underlying mood 
disorder or clinician ratings. Cognitive inflexibility predicted 
future suicidal ideation in those with a past history of self-harm 
(73). Rasmussen and colleagues found an association between 
recall of positive autobiographical memories, but not negative 
memories, and repetition of self-harm in an exploratory study 
(74). These studies indicate that poor functioning or impairments 
in terms of neurocognition may be associated with increased 
risk of repetition. However, it is less clear if we can apply these 
correlates clinically: that is, use assessment of these factors in an 
individual to predict the risk of future self-harm. This personal-
ized neurocognitive profile might also provide potential targets 
for therapeutic interventions aimed at reducing this risk.
HOW cOULD NeUrOcOGNitiON Be 
UseD tO GUiDe treAtMeNt FOr 
rePetitiON OF seLF-HArM?
Extrapolating from the non-repetition data, there may be several 
potential neurocognitive avenues to identify risk of repeating 
self-harm, and potential modes of intervention. Psychotherapy 
techniques may be helpful, such as cognitive therapy or train-
ing (75, 76), or dialectical behavioral therapy in situations such 
as personality disorder (77). However, there have been few 
replications of psychological therapies for self-harm (19) and 
no specific work in multiple attempters. For adolescents with 
multiple episodes of self-harm, mentalization therapy (based on 
understanding actions in terms of thoughts and feelings) (78) 
shows promise at reducing repetition frequency (79), but the 
effect was modest and the one trial was small (80). Non-invasive 
neurophysiological techniques, such as repetitive transcranial 
magnetic stimulation (rTMS), may prove to be effective (81–83). 
For example, we can increase risky decision-making in men by 
inhibiting cortical function with TMS (84). Therefore, may it be 
possible to improve cognition and ineffective decision-making 
by a similar method, for example, as van Heeringen suggests, by 
directing rTMS at the DLPFC to modify function in the OFC and 
hopefully reduce risky decisions (47)?
Previous investigations into potential medical treatments for 
self-harm have included antidepressants, mood stabilizers, and 
natural products, but no significant treatment effect on repeti-
tion of self-harm was found for any of these options in a recent 
Cochrane review, although the quality of evidence was low (85). 
Only one antipsychotic, Flupenthixol showed promise, but again 
the quality of the evidence was very low. However, perhaps we 
are not examining the correct potential medication in the correct 
circumstance. We know that emotional processing, in particular, 
is controlled by serotonin, and relates to amygdala functioning. 
However, amygdala responses to fearful faces are modified by 
antidepressant use in depressed patients (86, 87). If we could 
identify a group of individuals with self-harm behavior and 
emotional-processing deficiencies, might they receive a par-
ticular benefit from antidepressants? A large body of evidence 
indicates that Lithium and Clozapine are anti-suicidal unrelated 
to their efficacy as a mood stabilizer and antipsychotic, respec-
tively, possibly related to their serotoninergic effects (88, 89), 
as well as Lithium’s effect of reducing cell death and potentially 
increasing brain volume (90). However, as yet, there has been 
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little or no practice of using Lithium or Clozapine as a preven-
tion strategy outside of mood disorder (or violent behavior), or 
psychotic disorder, respectively. These may also be an avenue for 
further exploration. Furthermore, could we consider existing 
pharmacological regimes than have evidence for promoting non-
emotional neurocognition and memory in other disorders, such 
as acetylcholinesterase inhibitors typically used for Alzheimer’s 
dementia? Another possibility for further research is ketamine, 
an NMDA antagonist that is finding increasing support for its use 
as an antidepressant (91). Rapid suppression of suicidal ideation 
has also been noticed in depressed patients treated with ketamine 
(92), making it a potential treatment for high-risk suicidal idea-
tion to prevent imminent self-harm (93). However, the specific 
brain regions involved in ketamine’s ability to reduce suicidal 
ideation are unknown and much further work is required, 
including animal studies or similar before it can be considered 
for clinical trials.
Therefore, the dearth of imaging studies examining repetition 
in particular is concerning considering the individual, financial, 
and social implications of people who repeat self-harm fre-
quently and/or die by suicide. Until we investigate the functional 
neurocognitive basis underlying repetition of self-harm in a basic-
science (i.e., brain regions and networks) and systematic manner 
using second-generational imaging techniques, we will be unable 
to inform third-generational imaging and potential future clinical 
applications, of which there may be many. Potentially combining 
research into imaging and genetics may yield fruit, particularly in 
terms of neurochemistry alleles. However, clearing several process 
issues may help, such as reaching a consensus in terms of phe-
nomenology of self-harm and associated thoughts and behaviors.
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